Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

HCPCS Code A4231: Infusion set for external insulin pump, needle type

Key Takeaways

Key Takeaways

HCPCS Code A4231 describes a needle-type infusion set for an external insulin pump, used in CSII therapy billing.

Medicare covers A4231 under DMEPOS when medical necessity is documented and a Certificate of Medical Necessity is on file.

The KX modifier is commonly required to confirm documentation meets LCD requirements; missing it triggers automatic denial.

Pabau’s claims management software helps DME suppliers track modifiers, quantity limits, and documentation for A4231 claims.

Most A4231 claim denials come down to one of three problems: a missing modifier, a mismatched ICD-10 code, or an undocumented Certificate of Medical Necessity. Billing staff at DME suppliers lose hours chasing these rejections because the code looks straightforward on paper but carries specific Medicare requirements that competitors’ code-lookup pages gloss over. This guide covers the official description, Medicare DMEPOS coverage requirements, 2026 fee schedule context, required ICD-10 diagnosis pairings, modifier rules, quantity limits, and a step-by-step billing workflow for HCPCS Code A4231.

HCPCS Code A4231: Official description and code details

HCPCS Code A4231 is a Level II HCPCS supply code that describes an infusion set for an external insulin pump, specifically the needle type. It is maintained by the Centers for Medicare & Medicaid Services (CMS) as part of the DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) category.

Attribute Value
HCPCS Code A4231
Official Description Infusion set for external insulin pump, needle type
Code Status Active (2026)
Category Durable Medical Equipment (DME)
HCPCS Level Level II (A-series supply codes)
Type of Service DMEPOS Supply
Effective Date Active; verify current FY status via CMS annually

The “needle type” designation is the critical differentiator for this code. It distinguishes A4231 from A4230 (catheter type), which covers an infusion set for the same external insulin pump device but using a different insertion mechanism. Coders frequently bill the wrong code when documentation does not specify the set type. For a full lookup, AAPC’s HCPCS Level II code range tool allows filtering by the A-series and confirming descriptor accuracy.

Clinical use: when is HCPCS Code A4231 applied?

HCPCS Code A4231 is billed when a patient on continuous subcutaneous insulin infusion (CSII) therapy requires a replacement needle-type infusion set for their external insulin pump. CSII delivers basal and bolus insulin doses via a programmable pump worn by the patient, with the infusion set connecting the pump reservoir to the subcutaneous tissue.

Clinical scenarios where A4231 applies include: patients with Type 1 diabetes (insulin-dependent) managed on CSII, and select Type 2 patients whose physician has documented medical necessity for pump therapy over multiple daily injections. Patients typically replace their infusion sets every 2-3 days to reduce infection risk and maintain insulin delivery accuracy. Each replacement set is a separately billable supply under HCPCS Code A4231.

  • Type 1 diabetes (E10-series ICD-10): Primary indication for CSII therapy and A4231 billing
  • Insulin-dependent Type 2 diabetes: Eligible when physician documents medical necessity for pump therapy
  • Needle-type insertion sets specifically: Used when the patient’s pump protocol calls for a needle (steel) cannula rather than a soft (catheter) cannula
  • External pump only: A4231 does not apply to implantable pump supplies, which use separate HCPCS codes

DME suppliers billing this code should ensure clinical documentation specifies “needle type” explicitly. Using prescription management software that captures device type and supply specifications at the point of order reduces documentation gaps that lead to post-claim audits.

Stop wasting consultation time on prescription admin
Stop wasting consultation time on prescription admin

Medicare coverage and medical necessity criteria for HCPCS Code A4231

Medicare covers HCPCS Code A4231 under the DMEPOS benefit when medical necessity is documented according to the applicable Local Coverage Determination (LCD). CMS Policy Article A52507 governs external infusion pump supplies, including infusion sets. Coverage is not automatic; the supplier must have a valid Certificate of Medical Necessity (CMN) on file before billing.

Maintaining medical necessity documentation forms that align with CMS requirements reduces audit exposure significantly. Key coverage requirements include:

  • Physician order: A written order from the treating physician specifying the external insulin pump and infusion set type (needle)
  • Certificate of Medical Necessity: CMS Form 10126 or equivalent, signed by the physician, on file with the supplier prior to delivery
  • Insulin-dependent diabetes diagnosis: ICD-10 codes from the covered diagnosis list must support the claim
  • Face-to-face requirement: For new DMEPOS orders, the beneficiary must have had a face-to-face clinical encounter with the ordering physician within the timeframe specified by the LCD
  • LCD compliance: The claim must align with the active LCD for external infusion pumps; verify the current determination via the CMS fee schedule and coverage lookup

Ensuring HIPAA compliance for clinic software used to store and transmit CMN documentation is a parallel obligation for any DME supplier managing Medicare beneficiary records. Coverage without proper documentation is the leading reason for post-payment recoupment in DMEPOS audits.

A4231 fee schedule and reimbursement rates (2026)

Medicare reimburses HCPCS Code A4231 under the DMEPOS fee schedule, which CMS updates annually. Rates vary by jurisdiction (A, B, C, D) based on the Pricing, Data Analysis, and Coding (PDAC) contractor and competitive bidding program status in each service area. The figures below represent approximate allowed amounts for illustrative reference; always verify the current year’s rates from the CMS DMEPOS fee schedule file via PGM Billing’s HCPCS lookup before billing.

Fee Schedule Element Notes
Reimbursement basis Medicare DMEPOS fee schedule; purchase (not rental)
Jurisdiction variation Rates differ across Jurisdictions A, B, C, D; competitive bidding areas may have adjusted rates
Competitive bidding In competitive bidding areas (CBAs), contract suppliers only; non-contract suppliers cannot bill Medicare for A4231
Non-CBAs Fee schedule rates apply; Medicare pays 80% of allowed amount after deductible; beneficiary owes 20% coinsurance
Crossover payers Medicaid and secondary insurers may have separate allowed amounts; verify per-payer

Suppliers operating in competitive bidding areas must confirm their contract status before submitting any claim for HCPCS Code A4231. Billing Medicare for a CBR-designated product without an active contract results in automatic denial and potential False Claims Act exposure.

ICD-10 diagnosis codes for A4231 billing

Every HCPCS Code A4231 claim requires a supporting ICD-10 diagnosis code that establishes medical necessity for CSII therapy. Medicare’s LCD for external infusion pumps specifies covered diagnoses; the primary category is insulin-dependent diabetes mellitus (Type 1). Billing with an unsupported diagnosis code is among the top reasons for denial.

ICD-10-CM Code Description Coverage notes
E10.9 Type 1 diabetes mellitus without complications Primary covered diagnosis for CSII/pump therapy
E10.649 Type 1 diabetes mellitus with hypoglycemia without coma Commonly cited when recurrent hypoglycemia supports pump therapy
E10.65 Type 1 diabetes mellitus with hyperglycemia Supports medical necessity when glycemic control is inadequate on injections
E11.649 Type 2 diabetes mellitus with hypoglycemia without coma May be covered when physician documents insulin-dependent status; verify current LCD

Important: The ICD-10 codes above are commonly cited in LCD crosswalk references. Always verify the active covered diagnosis list against the current CMS LCD for external infusion pumps before submitting claims, as covered diagnoses can change with annual LCD updates. Using digital intake forms that capture patient diagnosis information in a structured, codeable format streamlines this verification step at the point of order.

Customizable consent and intake forms
Customizable consent and intake forms

Billing guidelines, modifiers, and quantity limits for HCPCS Code A4231

Modifier selection and quantity compliance are where most A4231 claims run into trouble. The billing rules for DMEPOS supplies differ from physician fee schedule claims, and applying the wrong modifier or submitting above the allowed quantity triggers automatic edits.

Required modifiers

Modifier Description When to use
KX Documentation on file confirms LCD requirements are met Required when billing Medicare; confirms CMN and clinical documentation are complete
GA Waiver of liability statement on file When coverage may be denied; indicates ABN is on file with beneficiary
GY Item or service is not covered by Medicare When supply does not meet LCD criteria; used to obtain a denial for secondary billing

The KX modifier is the most critical for routine A4231 Medicare billing. Submitting without KX when documentation exists leaves money on the table. Submitting KX when documentation is incomplete exposes the supplier to recoupment. Verify documentation status before every claim submission using a workflow that flags incomplete CMN files before the billing queue.

Quantity limits

Medicare applies quantity limits to insulin pump supplies, including HCPCS Code A4231, through the applicable LCD. Monthly supply quantities are based on the patient’s pump usage protocol and documented medical necessity. The specific per-month unit limit must be verified against the current active LCD, as CMS adjusts these periodically. Billing above the allowed quantity without prior authorization documentation results in automatic claim edits and denial of excess units.

Tracking monthly supply quantities per beneficiary requires a billing system that can flag when a patient approaches their limit within a calendar month. Using claims management software with built-in quantity tracking prevents inadvertent overbilling, which is both a denial risk and a compliance concern under Medicare’s DMEPOS rules. Ensure all HIPAA-compliant billing documentation is retained per the applicable record retention schedule.

Fully Integrated with Pabau Billing
Fully Integrated with Pabau Billing

Pro Tip

Flag all A4231 claims for a two-step review before submission: first confirm the KX modifier is supported by a complete CMN on file, then verify the claim quantity does not exceed the beneficiary’s monthly limit for the billing period. This two-gate check eliminates the two most common denial reasons in a single workflow step.

The A4230-A4233 code range covers infusion sets and related supplies for external insulin pumps. Selecting the wrong code from this cluster is a frequent billing error. Each code maps to a specific supply type and pump configuration. See other DME procedure codes for additional supply code context across HCPCS categories.

HCPCS Code Description Key distinction
A4230 Infusion set for external insulin pump, catheter type Soft (Teflon/nylon) cannula; most common for modern pump users
A4231 Infusion set for external insulin pump, needle type Steel needle cannula; remains in place during wear; less common but still prescribed
A4232 Syringe with needle for external insulin pump, sterile, 3 cc Reservoir syringe for loading insulin into the pump; separate supply from the infusion set
A4233 Replacement battery, alkaline (other than 9-volt) Pump battery replacement; distinct supply category from infusion sets

A4230 and A4231 are the most commonly confused pair. The clinical distinction is in the cannula material and insertion mechanism. A needle-type set (A4231) uses a steel needle that stays in the subcutaneous tissue throughout the wear period. A catheter-type set (A4230) uses a soft cannula that is inserted via a needle guide, which is then removed, leaving only the flexible catheter in place. Documentation from the prescribing physician must specify which type the patient uses.

How to bill HCPCS Code A4231: step-by-step for DME suppliers

Competitor code-lookup pages list attributes for HCPCS Code A4231 but skip the workflow. Here is the end-to-end billing process for DME suppliers submitting A4231 claims to Medicare. Using medical practice management software that integrates with your billing queue makes each step faster and auditable.

  1. Obtain a written physician order specifying the external insulin pump and infusion set type (needle type). The order must precede delivery of the supply.
  2. Collect and verify the Certificate of Medical Necessity (CMN) using CMS Form 10126. Confirm it is completed, signed by the ordering physician, and dated before the supply was delivered.
  3. Confirm the ICD-10 diagnosis code on the CMN matches a covered diagnosis in the current LCD. Cross-check against the active covered diagnosis list before proceeding.
  4. Verify the beneficiary’s competitive bidding status. If the delivery address falls within a competitive bidding area, confirm your contract status for this product category before submission.
  5. Determine the correct modifier. Attach KX if documentation confirms LCD compliance. Attach GA if an Advance Beneficiary Notice (ABN) is on file. Use GY if the item does not meet coverage criteria and you need a formal denial for secondary billing.
  6. Check quantity against the monthly limit. Confirm the units being billed do not exceed the beneficiary’s allowed quantity for the billing month under the active LCD.
  7. Submit the claim on a CMS-1500 form (or electronic equivalent) with the correct HCPCS Code A4231, modifier, quantity, ICD-10 code, and supplier NPI.
  8. Track the remittance advice. Review the ERA for denial codes. Common denial reason codes for A4231 include CO-4 (modifier mismatch), CO-50 (not medically necessary), and CO-119 (quantity exceeds limit).

Integrating EHR integration for DME billing workflows with your claim submission process ensures that CMN data, diagnosis codes, and physician orders flow directly into the billing record, reducing manual transcription errors that generate step 7 and 8 failures.

Streamline your DME billing documentation with Pabau

Pabau's claims management tools help DME suppliers and clinic billing teams track modifier requirements, maintain compliant documentation, and reduce claim denials for DMEPOS supply codes like A4231.

Pabau claims management dashboard

Common billing errors and how to avoid them

HCPCS Code A4231 has a predictable denial pattern. The same four errors appear repeatedly across DMEPOS audits and AAPC member forum discussions. Addressing each one in your pre-submission workflow eliminates the majority of rejections.

  • Missing KX modifier: Submitting A4231 to Medicare without KX when valid documentation exists generates an automatic CO-4 denial. The fix is a documentation-complete checklist that gates modifier assignment at claim creation, not after denial receipt.
  • Wrong infusion set code (A4230 vs A4231): Billing A4230 when the physician order specifies a needle-type set, or vice versa, results in a code-mismatch denial. Ensure the intake documentation captures “needle type” or “catheter type” explicitly and map that field to the HCPCS code selection in your billing system.
  • Unsupported ICD-10 pairing: Using a non-covered ICD-10 code (for example, a Type 2 diabetes code without documented insulin-dependent status) triggers a CO-50 (not medically necessary) denial. Cross-reference the diagnosis code against the covered list in the LCD before submission on every claim, not just new patients.
  • Exceeding quantity limits without authorization: Submitting more units than the LCD allows per month without documented clinical justification for higher utilization generates a CO-119 denial. Track monthly unit counts per beneficiary and flag claims that approach the limit before submission.
  • Billing in competitive bidding areas without contract: Non-contract suppliers who bill Medicare for HCPCS Code A4231 in a CBA receive a CO-182 denial and face potential compliance action. Verify CBA status by ZIP code before accepting any order. Using patient data security tools that log order intake details with location data helps flag CBA status at the point of order entry.

Pro Tip

Build a five-field pre-submission checklist for every A4231 claim: (1) CMN complete and signed, (2) ICD-10 code on covered list, (3) KX modifier attached, (4) units within monthly limit, (5) CBA status confirmed. Claims that clear all five fields have near-zero routine denial rates.

Conclusion

HCPCS Code A4231 is straightforward to describe but operationally complex to bill correctly. The gap between code definition and clean claim submission sits in the details: modifier selection, ICD-10 pairing, CMN documentation, quantity tracking, and CBA verification. Each step has a predictable failure mode that experienced billing staff encounter repeatedly.

Pabau’s claims management software gives DME suppliers and clinic billing teams a structured workflow to manage documentation requirements, track quantity limits, and reduce denial rates on DMEPOS supply codes. To see how Pabau handles DME billing documentation, book a demo with the team.

Continue your research

Continue your research

Need compliant documentation templates for DME orders? Medical forms at your healthcare practice covers how structured digital forms reduce documentation gaps that trigger DMEPOS claim denials.

Managing multi-payer billing workflows? Practice management system vs EMR explains how integrated practice management helps billing teams maintain compliant records across Medicare and secondary payers.

Looking to reduce documentation burden on clinical staff? EHR integration for billing workflows outlines how connected systems eliminate manual transcription errors between clinical orders and HCPCS claim submissions.

Frequently Asked Questions

What is HCPCS Code A4231 used for?

HCPCS Code A4231 is a Level II supply code used to bill Medicare and other payers for a needle-type infusion set for an external insulin pump. It covers the consumable delivery set that connects the pump reservoir to the patient’s subcutaneous tissue in continuous subcutaneous insulin infusion (CSII) therapy.

What is the difference between A4230 and A4231?

A4230 covers an infusion set for an external insulin pump using a catheter (soft cannula) type, while A4231 covers the needle (steel cannula) type. The physician order and clinical documentation must specify which type the patient uses; billing the wrong code results in a mismatch denial.

Does Medicare cover HCPCS Code A4231?

Yes, Medicare covers HCPCS Code A4231 under the DMEPOS benefit when a valid Certificate of Medical Necessity is on file, the claim includes an appropriate ICD-10 diagnosis from the LCD’s covered list, and the KX modifier confirms documentation compliance. Coverage is subject to the active Local Coverage Determination for external infusion pumps.

What ICD-10 codes are required for A4231 billing?

The primary supported diagnoses are Type 1 diabetes mellitus codes in the E10-series (e.g., E10.9, E10.649, E10.65). Select Type 2 insulin-dependent diabetes codes may also be covered when physician documentation establishes medical necessity. Always verify against the current CMS LCD covered diagnosis list before submitting.

What modifiers are used with A4231?

The KX modifier is required on most Medicare A4231 claims to confirm that documentation meets LCD requirements. GA is used when an Advance Beneficiary Notice is on file and coverage may be denied. GY is used when the item does not meet Medicare coverage criteria and a formal denial is needed for secondary payer billing.

How many A4231 units does Medicare allow per month?

Monthly quantity limits for HCPCS Code A4231 are set by the applicable LCD and may be adjusted with annual CMS updates. The specific per-month unit ceiling must be verified against the active coverage determination before billing; submitting above the limit without documented clinical justification triggers a CO-119 denial.

×